Four Myths About Melanoma

Accurate knowledge is key for prevention, detection and also treatment.

When it comes to melanoma and other skin cancers, misconceptions abound. It is important to understand what will help prevent them and what might actually increase a person's risk. Here are four common myths related to melanoma and other skin cancers.

MYTH: Dark skin doesn't burn so those with it won't get skin cancer.

FACT: All skin types and ethnic groups can contract skin cancer. Although it is true that Caucasians have a greater risk of skin-related cancer, everyone should protect their skin against UV rays. Although fair-skinned people can fairly easily see stage 1 melanoma and other cancers, darker skin makes catching it in the early stages more unlikely. In fact, Hispanics and African-Americans who have contracted skin cancer have a noticeably higher mortality rate, often due to having it diagnosed in later stages.

MYTH: Putting on sunscreen as soon as one gets to the beach will protect against skin cancer.

FACT: Sunscreen takes about an hour to really get absorbed by skin. Although it will still make a difference, a person won't have total protection until it has been absorbed. Additionally, applying sunscreen hourly while in the sun is highly recommended. Also, people should make sure to choose a broad-spectrum sunscreen, especially those with fair skin.

MYTH: Unexposed skin can't get melanoma and doesn't need to be checked.

FACT: Unfortunately, melanoma can be contracted on the soles of feet, beneath toenails and fingernails, in some organs and even in eyes. Whether skin is exposed or not, it is still at risk of melanoma and should be checked during a cancer screening.

MYTH: Only people who tan regularly get skin cancer.

FACT: Anyone can get melanoma or other skin-related cancers. If there are any signs that a mole is changing shape or color, or a patch of skin has become harder or discolored, a doctor should be consulted. If cancer is detected, it is important to keep abreast of the latest advances in treatment. For example, San Diego-based OncoSec Medical Inc. has developed ImmunoPulse, which involves the application of a brief electric field to the surface of the skin, causing pores to temporarily open in the membrane of tumor cells. This allows an anticancer agent to be absorbed more efficiently so that it can do its job of stimulating the immune system's T-cells to fight the cancer.

For more information, please visit www.oncosec.com.

Related Media